Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $201.0B |
| Sales growthchange from the year before | +22.2% |
| Gross marginshare of sales left after the direct cost of what it sells | 82.0% |
| Operating marginshare of sales left after running the business | 41.4% |
| Net marginshare of sales kept as profit | 30.1% |
| Free-cash-flow marginspare cash generated per $100 of sales | 22.9% |
| Return on invested capitalprofit made on each $100 put into the business | 23.8% |
| Return on equityprofit vs. shareholders' accounting value | 27.8% |
| Debt / equitydebt vs. shareholders' accounting value | 0.27 |
| Interest coverhow many times profit covers interest payments | 76.4x |
| Change in share countnegative = the company is buying back its shares | -1.5% |
3 insiders sold $2.4M (all under pre-arranged plans) on the open market.
| Kimmitt Robert MDirector | Sold (plan)Aug 3 | 500 shat $561.56 · $281K |
| Alford PeggyDirector | Sold (plan)Jul 31 | 464 shat $543.56 · $252K |
| Olivan JavierChief Operating Officer | Sold (plan)Jul 27 | 1,466 shat $607.85 · $891K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy